July 21, 2007

Contact:
Phil Meeks, CEO
Azopharma Contract Pharmaceutical Services
10320 USA Today Way
Miramar FL 33025
Phone: 954-433-7480
www.azopharma.com

Azopharma has reached an agreement to purchase certain facility assets and assume occupation of a research and development facility in Hollywood, Florida, previously operated by Kos Pharmaceuticals.Azopharma CEO Phil Meeks states, “We are pleased about the addition of our new facility in Hollywood, Florida, and our expanded capacity to manufacture cGMP Clinical Trial Material. This acquisition will significantly increase our ability to support our customers and our Phase I ExpressTM process.  Phase I ExpressTM enables our customers to move quickly and efficiently toward clinical trials. Phase I ExpressTM includes preclinical, preformulation, formulation development, analytical R&D, QC release, stability, manufacturing, packaging and labeling of clinical supplies for Phase I, studies.”
 
Our facilities in Florida are FDA registered and inspected, DEA approved and client audited on a routine basis. We are registered with the DEA for testing all schedules of controlled drugs and also have individual licensing for manufacture on an as requested basis. Our sites are fully cGMP compliant per the FDA and we have an independent Quality Assurance program that performs 100% inspections of all reported data.

Azopharma’s mission is to help our customers turn ideas into cures. In product development, it all comes down to the right people, their commitment and application of experience. Partnering with the right people, with the right experience can give you the confidence of assured success. We welcome visits to our facility in South Florida to conduct audits or meet with our pharmaceutical scientists to outline a study that meets your specific needs. Contact us at development@azopharma.com or 954-433-7480.